Practical considerations for the use of mTOR inhibitors.
Immunosuppressive therapy after kidney transplantation is based on calcineurin inhibitors (CNI). In most cases CNI therapy is combined with mycophenolate and steroids. In spite of good short-term results this therapy is associated with long-term toxicities, graft loss and patient death. Therefore, alternative immunosuppressive strategies are needed that combine excellent efficacy with low incidences of long-term adverse outcomes. This review focuses on the strategies based on mTOR- inhibitors in combination with minimized exposure to CNI.
Department of Nephrology and Kidney Transplantation, Hospital Clínic, Villarroel, 170, E-08036 Barcelona, Spain ; Servicio de Nefrología - Clinical Institute of Nephrology and Urology, Hospital Clinic, Barcelona, Spain.
Fritz
F
Diekmann
Department of Nephrology and Kidney Transplantation, Hospital Clínic, Villarroel, 170, E-08036 Barcelona, Spain.
Josep M
JM
Campistol
Calcineurin inhibitors; Kidney transplantation; Nephrotoxicity; Post-transplant malignancy; mTOR-inhibitors